SpringWorks Therapeutics

Pfizer spinout SpringWorks gets FDA priority review for lead drug
Endpoints
Mon, 02/27/23 - 10:14 am
SpringWorks Therapeutics
Pfizer
nirogacestat
desmoid tumors
FDA
priority review
SpringWorks, Eli Lilly and More Release Data Ahead of ESMO
BioSpace
Thu, 09/8/22 - 04:30 pm
SpringWorks Therapeutics
nirogacestat
desmoid tumors
Eli Lilly
ESMO
Pfizer spinout SpringWorks will ship its first drug to the FDA before year’s end with PhIII win
Endpoints
Tue, 05/24/22 - 10:46 am
Pfizer
SpringWorks Therapeutics
spinoffs
oncology
FDA
clinical trials
nirogacestat
desmoid tumors
Allogene, SpringWorks to Test Drug Combo in Multiple Myeloma Trial
Xconomy
Mon, 01/13/20 - 10:25 am
SpringWorks Therapeutics
Allogene
Multiple Myeloma
clinical trials
ALLO-715
nirogacestat
SpringWorks Therapeutics Updates Filing for $143+ Million IPO
CP Wire
Tue, 09/3/19 - 10:26 am
SpringWorks Therapeutics
IPOs
nirogacestat
mirdametinib
Pfizer
SpringWorks Therapeutics Updates Filing for $143+ Million IPO
Tue, 09/3/19 - 09:50 am
SpringWorks Therapeutics
IPOs
nirogacestat
mirdametinib
Pfizer
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
Xconomy
Sat, 08/17/19 - 01:28 pm
IPOs
SpringWorks Therapeutics
Pfizer
Satsuma Pharmaceuticals
Pfizer biotech spinout nabs $125M megaround as Bain-backed syndicate bets on its late-stage game plan
Endpoints
Mon, 04/1/19 - 12:35 pm
Pfizer
SpringWorks Therapeutics
nirogacestat
PD-0325901
In A First, Pfizer Spins Out Biotech Firm With $103 Million In Funding
Forbes
Mon, 09/25/17 - 09:52 am
Pfizer
biotech
spinoff
SpringWorks Therapeutics